by Barbara Rath
The ViVI Score mobile app has been scientifically validated and is now available in the Apple Store and Google Playstore for doctors and healthcare providers interested in participating in the PEDSIDEA program.
PEDSIDEA stands for "Partnering for Enhanced Digital Surveillance of Influenza-like Disease and the Effect of Antivirals and Vaccines". The program started in Europe and is now extended to hospitals and community clinics in the USA.
The layperson version for patient-reported outcomes, ViVI ScoreMe, and a new version specifically for people living with diabetes, ViVi ScoreDM, will be developed through this Campaign.
This current flu season is no exception: scary news headlines are abundant, describing how healthy young people may become very ill from the flu. Some have died. This may be rare, but who could have known ahead of time that they were at risk? Did they really "just think they had a simple cold" or "ignore their symptoms for too long"? Don't we usually do the same? Do we know our personal risks, and do we know when we need to see a doctor? What about our children? What can we do to keep them safe and to give our doctors the information they need to take the right decisions at the right time?
The ViVI ScoreMe mobile app for patient-reported outcomes will help patients and their families to monitor flu symptoms based on scientific criteria. That way we can give doctors the most important information they need to take the right decisions.
Experts tell us that there are groups of individuals that may carry an even greater risk: Diabetes is one of the most important risk factors for severe flu. For overweight people, the risk may increase even further.
What does this mean to me as a person living with diabetes?
The ViVI ScoreDM mobile app for people living with diabetes will help me record symptoms to communicate with my doctor more efficiently. That way, I can adjust insulin and medication needs in time, while gaining a better understanding of flu and diabetes and how these conditions may influence each other.
Every year during flu season, emergency rooms are crowded with patients complaining of flu-like symptoms and acute respiratory infections. Even though most cases are viral in origin, antibiotics are prescribed frequently. As physicians, we are worried about missing a rare case, when a simple flu may progress to a serious or even life-threatening condition. Those of us taking care of children know that initial symptoms may be subtle and non-specific. Here, we find it even more challenging to know ahead of time, who may need special attention and who can be sent back home safely. When a patient is admitted to the hospital, how do we monitor progress consistently, and how do we communicate disease severity during rounds or during sign-over from one shift to another?
The Vienna Vaccine Safety Initiative (ViVI), an international scientific think tank and non-profit organization, developed the first prospectively validated disease severity score for influenza and other respiratory viral infections, which can be used consistently in infants and children as well as in adults. It was developed based on extensive literature review aligned with WHO criteria for uncomplicated and complicated disease.
The ViVI Disease Severity Score has since undergone extensive scientific validation in large cohorts and multi-center studies in collaboration with public health agencies in Europe and the US.
We are interested in working with you, to learn how you would integrate the ViVI Score mobile app into your clinic routines and how it will help you improve quality of care and risk communication.
In collaboration with patient organizations, we are developing a layperson version for patient-reported outcomes (ViVI ScoreMe) allowing patients and parents to track flu symptoms using the same scientific criteria. We expect that this will help them communicate with you, their healthcare provider, more efficiently.
For patients with diabetes (ViVI ScoreDM) we are developing a specific version of the app allowing the integration of key parameters for diabetics care, such as insulin and medication needs. This will enable us to gain a better understanding of the interaction of a complex metabolic condition with influenza and other respiratory viral infections.
Modern healthcare requires attention to detail as well as to the big picture. As an institution, you are expected to improve quality of care continuously, and to track patient outcomes consistently. Acute respiratory infections as unpredictable as the flu, may impact entire healthcare systems. Recent reports of the 2017/18 flu seasons in the Southern as well as the Northern Hemisphere, have illustrated this challenge once again.
The ViVI Score was specifically developed to meet this need when taking care of patients with influenza and other respiratory viral infections. It was developed out of the need to streamline triage procedures, patient flow, surveillance data, antibiotic stewardship and cost effectiveness. And most importantly, we intend to improve safety and patient satisfaction.
The ViVI Score mobile app allows healthcare professionals to quickly assess known risk factors and score disease severity within a few minutes. It can be used without any additional training – its user-friendly, intuitive design emerged from rapid prototyping and multiple iterations in direct collaboration between software developers and clinicians. The app was scientifically validated and studied extensively in the context of closely monitored, IRB approved quality improvement programs.
We are now interested in taking this tool to the next level. The development of a compatible patient-reporting tool (ViVI ScoreMe) is underway, as well as a specific version of the Score, ViVI ScoreDM for patients with diabetes mellitus. Adopting this state-of-the digital tool to the special needs of patients with diabetes, will help us tackle a challenge that often "falls through the cracks" between medical subspecialties.
The Vienna Vaccine Safety Initiative has a strong track record of combining the user-friendly innovation technique of Design Thinking with the scrutiny of scientific research, leading to the development of novel, reliable and well-designed tools for quality improvement and patient safety.
We are always interested in partnering with healthcare providers to ensure that our inventions and developments will improve patient safety and the interaction between patients and providers. Contact us at email@example.com for more information.
The cost of seasonal influenza is immense.
As a non-profit organization we see it as our task to help healthcare providers use their resources more efficiently while improving quality of care to the patient’s benefit.
Studies have demonstrated the potential impact of the ViVI Score on antibiotic stewardship and cost effectiveness.
F Tief, C Hoppe, L Seeber, P Obermeier, X Chen, K Karsch, S Mühlhans, E Adamou, T Conrad, B Schweiger, T Adam, B Rath:
An inception cohort study assessing the role of pneumococcal and other bacterial pathogens in children with influenza and ILI and a clinical decision model for stringent antibiotic use
Antiviral Therapy 2016, 21(5):413-24. doi: 10.3851/IMP3034. Epub 2016 Feb 11. PMID: 26867096
Additional studies in different healthcare settings are underway.
The ViVI Score is the first disease severity score for children and adults with influenza and other respiratory viral infections that has undergone large-scale prospective validation and scientific peer review. We plan to continue leading the field by being the first to market.
As a non-profit organization, our focus has been on research and development rather than sales revenue.
Our apps will be made available to different user groups, providing different user profiles and modes of access.
We are "radically interdisciplinary scientific physician-innovators with a passion for the arts". We thrive in buzzing, creative environments and academic medicine.
After 10 years of incubation in Europe, we decided to establish a US non-profit organization in New Orleans.
This is a natural fit. We are working with local app developers. Our collaboration with local community clinics keeps us grounded.